OpenDDE is a preview release. CLI flags, input/output JSON fields, and released checkpoints may change between versions, and predictions are not guaranteed to be reproducible across releases. It is ...
Rep. Lieu suggests Trump is taking a 'special drug' meant for terminal illness patients. Lincoln Memorial pool 'gash' mystery might finally be answered US will take control of Strait of Hormuz, charge ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The White House has denied that President Donald Trump was given an ...
“How do they do that?” is a reasonable response to certain things we see in nature. Pythons and snakes like them can eat prey as big as they are, sometimes even bigger, and digest their massive single ...
FDA's Adam Fisher speaks at the 2026 REdI meeting. (Source: REdI) Adam Fisher, the staff director of the Office of Pharmaceutical Quality in the Center for Drug Evaluation and Research (CDER) at the ...
The FDA has approved AstraZeneca’s Baxfendy to treat uncontrolled hypertension, marking the first approval for an aldosterone synthase inhibitor in the indication. Baxfendy, also known as baxdrostat, ...
Baxfendy, the first aldosterone synthase inhibitor to be approved by the FDA for high blood pressure, is among the products AstraZeneca is relying on to hit its 2030 goal of $80 billion in revenue.
A Texas couple whose son died of an overdose in 2025 after using OpenAI's ChatGPT tool to get information about drugs sued the technology company on Tuesday, blaming the AI platform for his death.
The National Drug Control Strategy is prepared biennially by the Office of National Drug Control Policy. This document provides a strategic roadmap for the Administration to continue dismantling the ...
Eli Lilly LLY-1.21%decrease; down pointing triangle Chief Executive Dave Ricks was on stage with Nvidia NVDA 2.95%increase; up pointing triangle founder Jensen Huang earlier this year in San Francisco ...
The Justice Department reclassified marijuana from Schedule I to Schedule III as soon as April 22, according to a source. The shift does not legalize marijuana but could cut punitive taxes and expand ...